We clearly live in a golden age for innovation as, despite backward-looking concerns, funding and ideas feed off each other to support the next wave of productivity and products and services.
Month: March 2021
Tengyin takes Tencent funding
Tencent has supplied more than $15.4m in series A-plus funding for the marketing platform developer and reportedly holds a 3% stake.
Secureframe sucks in $18m
Gradient Ventures returned for the data compliance software developer’s series A round having co-led its seed round in October.
Tuya ties up $915m initial public offering
The Tencent-backed internet-of-things platform developer has reportedly priced its shares above their range and will list on the New York Stock Exchange.
Momenta finds path to $500m series C
Bosch, SAIC Motor and Toyota were among the investors that co-led a series C round for the driverless software provider that included Mercedes-Benz and Tencent.
SK Group and Geely rev up $300m fund
Automotive manufacturer Geely and conglomerate SK Group are each chipping in $30m for a mobility-focused investment vehicle.
Stelis stays course to raise $195m
The Strides-backed protein and peptide-based therapeutics developer has disclosed a $70m series B and $125m C round, valuing it at $350m post-money.
Yotpo gets $230m allotted to series F
The e-commerce marketing software provider boosted its valuation to $1.4bn in a round that included Access Industries’ Claltech subsidiary.
Fireblocks finds $133m in series C round
Swisscom, BNY Mellon and SVB Financial Group have invested in a round that boosted the the digital asset infrastructure provider’s overall funding to $179m.
Aktis Oncology acts to raise $72m
Novartis and Bristol Myers Squibb helped the alpha radiotherapy developer complete a series A round after being incubated by MPM Capital.
Overwolf hunts down new funding
Ubisoft, Warner Music Group, Intel Capital and Liberty Technology Venture Capital helped the game development platform provider secure $52.5m.
Investors fork over $13m to Fort Robotics
Prologis Ventures was among the participants in a round that will help the safety technology developer double the size of its team.
Madryn makes $57m investment in Bigfoot
Madryn Asset Management has provided debt and equity financing intended to help Abbott-backed Bigfoot Biomedical bring its diabetes management technology to market.
ExeVir Bio upgrades series A to $50m
UCB’s corporate venture capital unit has helped the antiviral treatment developer close its series A round, joining a $22.6m extension.